Abstract
There is a well-defined regulatory framework governing the approval of chemicals for use as pharmaceuticals or release into the environment. Toxicity assessment is thus a major hurdle in the compound discovery pipeline, currently involving large scale animal testing. The search for alternative testing platforms is therefore an important priority. We have developed a convenient, low cost assay utilising the nematode Caenorhabditis elegans, to rapidly assess both acute toxicity and developmental and reproductive toxicity (DART). However the worm is protected by a robust cuticle that forms a barrier to chemical uptake. We assessed mutants with altered cuticle properties to identify sensitized strains optimized for toxicity assays. Evaluating the trade-off between increased permeability and reduced fitness identifies bus-5(br19) as the most suitable strain for chemical exposure. We demonstrate the applicability of this assay for a range of chemicals with differing properties, including a modified exposure protocol for volatile or less soluble compounds. This work enhances the effectiveness of C. elegans for convenient toxicity assessment, which could contribute to a reduction in the use of vertebrates particularly at the crucial early stages of product development. Strains identified in this work will also enhance the sensitivity of C. elegans based drug discovery platforms.
Similar content being viewed by others
Introduction
There are stringent requirements for toxicity testing of chemicals involving both acute toxicity and developmental and reproductive toxicity (DART), particularly pertinent to the petrochemical, agrochemical and cosmetics industries in which chemicals are released into the environment. This testing involves large numbers of animals. Currently the regulatory framework for DART testing demands one (OECD 414) and two (OECD 416) generational studies of rats and rabbits and account for the use of thousands of animals per year1. Home Office figures reveal 556,000 animals were used in regulatory tests in 2015 in the UK alone (https://www.gov.uk/government/statistics/statistics-of-scientific-procedures-on-living-animals-great-britain-2015). Although the pharmaceutical industry is subject to different regulations by the Medicines and Health Care Products Regulatory Agency in the UK, any drugs taken chronically or by children have potential for DART and similar testing requirements apply.
The financial and ethical costs of using such large numbers of animals, together with the time taken for testing (resulting in opportunity costs for product development), means that alternative testing platforms are highly desirable2. Indeed animal testing has been banned within the European Union for cosmetics further driving the need for alternatives. Such platforms are envisioned to give an indication of toxicity potential early in the product development pipeline in order to eliminate high-risk compounds without the need to test on vertebrates. Initiatives to reduce animal testing in DART have focused mainly on outcomes from cell-based assays and the use of in silico approaches, yet none of these have been able to incorporate the complexity of the reproductive and developmental life cycle.
The nematode Caenorhabditis elegans, with its ease of manipulation and storage, short life cycle and low husbandry costs, has long been recognised as one of the premier model organisms for biological research. The worm shares many fundamental biological processes with humans, has a completely sequenced and fully annotated genome (together with a wealth of genomic reagents and resources), and is highly tractable at both the genetic and biochemical level. Comparative genomic studies have revealed that C. elegans contains many genes homologous to mammals3, 4 which make the worm a powerful biomedical tool for disease modelling, drug discovery and toxicity assessments5,6,7,8,9. The transparent nature of the worm, coupled with the invariant and completely described cell lineage, means that development is incredibly well defined, at single cell resolution, with a great many well described phenotypes associated with particular developmental perturbations. Development involves the vast majority of molecular signalling pathways common to human development and cell behaviour, and thus C. elegans offers great potential for developmental toxicity testing. In addition, the hermaphrodite nature of C. elegans, coupled with the short (3 day) generation time, means that trans-generational studies are particularly convenient, offering advantages for the study of reproductive toxicology.
C. elegans has been used to identify pharmacological targets for various human diseases, and is gaining increasing attention as a promising multicellular alternative for toxicity testing10,11,12,13. Positive predictive power of C. elegans for toxicological research has been shown. For example, one study demonstrated that 89% of compounds compromising egg viability in the worm also have known developmental effects in mammals14, while a study of 47 compounds associated with mammalian reproductive toxicity showed up to 69% concordance between C.elegans data and ToxRefDB mammalian data12. In a more extensive study, toxic effects associated with exposure of C. elegans to over 900 chemicals were compared with ToxCast data from zebrafish, rats and rabbits15. The authors found concordance of C. elegans data with data from rats and rabbits of between 45 and 53% across a range of doses, which is only slightly lower than the concordance between rat and rabbit data (58%).
Previous testing regimes in C. elegans have tended to focus on rather specific endpoints, such as increased apoptosis12, or have reported on only developmental but not reproductive effects14, 16, or reproduction only17 and this has been proposed to lead to a high percentage of compounds missed in these assays. For example, in an egg viability assay 75% of compounds which did not reduce egg viability do cause toxic effects in mammals14. In this work, we establish a rapid, convenient yet quantifiable assay capturing both acute toxicity and DART, by covering the whole developmental and reproductive life cycle.
One potential disadvantage of using nematodes in a chemical testing regime is that they are protected by a robust cuticle made of complex layers of collagen that functions as a physical barrier against impact of chemicals, toxins and pathogens18,19,20,21,22. One study revealed the concentration of 5-hydoxytryptophan to be 100–1000-fold lower inside an exposed worm than the concentration in the medium17. A high throughput screen of over 1000 small molecules revealed problems with drug accumulation inside worms in over 90% of cases23. This poses a problem for chemical testing because uptake appears to be compromised in C.elegans, and thereby toxic effects underestimated18. Mutant strains bearing compromised cuticles have been shown in some instances to facilitate chemical uptake, leading to increased sensitivity to particular agents.
Here, we have selected a group of candidates carrying mutations in the genes agmo-1, bus-5, bus-8, bus-16 and bus-17, all of which are known for their compromised cuticle. The Bus (bacterially unswollen) mutants were originally identified by their resistance to the nematode pathogen Microbacterium nematophilum 24, 25. bus-8 encodes a predicted glycosyltransferase that is required for epidermal integrity and production of the cuticle surface; mutants have been shown to display enhanced sensitivity to the neurotoxins nicotine, 1-phenoxypropan-2-ol and ivermectin26. bus-5 encodes the dTDP-glucose 4,6-dehydratase rml-2 and is required for dTDP rhamnose biosynthesis and is suggested to be a cuticular component27. bus-17 encodes a predicted galactosyl-transferase required for cuticle integrity, as evidenced by bleach sensitivity24, 28. bus-16 is uncloned but is also required for proper cuticle integrity24. agmo-1 (encoding an alkyl glycerol mono-oxygenase) is required for epidermal lipid metabolism involved in cuticle integrity29.
We determined cuticle permeability for the five selected strains and assessed this against potentially reduced fitness, which would be undesirable in a testing strain. Optimised strains were tested against a range of chemicals and the bus-5 mutant was found to combine features of enhanced permeability and chemical sensitivity with negligible fitness consequences. Overall, we have established an enhanced assay for both acute toxicity and DART assessment in C. elegans and an optimised strain for testing.
Results
Establishment of a plate based assay for toxicity assessment
Worms can easily be grown in a 24-well plate format on solid media throughout their developmental and reproductive cycle and this has previously been used as a convenient toxicity screening platform30. Firstly, we established that the optimal number of worms that can be grown on an individual well without exhausting the food supply before the completion of the reproductive cycle (one generation) was five animals (data not shown). When five L1s were picked onto a fresh well containing a lawn of OP50 bacteria, it was possible to observe both the development of the five P0 animals as well as the production and development of the next generation (F1). Wells were photographed over a period of 6 days, until the bacterial food source became completely exhausted and animals began to starve (Fig. 1a). The original larvae developed into adult worms by day 3 and significant numbers of live progeny are apparent by day 4. As food becomes depleted, the worms first accumulate at the edge of the food circle (a behaviour known as bordering) where bacterial growth is thickest, and this is apparent at day 5, before the bacterial lawn completely disappears (day 6). Developmental and reproductive rates were highly reproducible between replicate wells (data not shown).
In order to determine whether this fitness assay would be suitable for testing chemical toxicity we exposed the worms to different concentrations of boric acid, a widely used antiseptic that is known to cause DART in mammals (Fig. 1b). High concentrations of boric acid (12 mM and above) caused acute toxicity (death of P0 animals). Exposure to concentrations between 4.8 mM and 9 mM caused increasing developmental delay with associated delay in food depletion, with the higher concentration (9 mM) inhibiting progeny production (Fig. 1b). Exposure to concentrations of 12 mM or greater led to the death of the P0 animals. Thus, this assay can distinguish acute toxicity from DART and is simple and rapid to perform on solid medium (the preferred substrate for C. elegans analysis). The advantage of the assay is that it allows assessment of the same population of animals over the time course of chemical exposure. A potential disadvantage is the relatively high concentrations of chemical required to see an effect, with associated implications for cost and comparison with mammalian data.
Identification of testing strains with enhanced permeability
The relative insensitivity of C. elegans to chemicals is thought to be caused by the tough exterior cuticle imposing a barrier to uptake. We hypothesized that this could be overcome by using mutants with compromised cuticle integrity. To test this we assembled a panel of mutants with various defects in cuticle structure and assessed their permeability. Previous reports have utilised assays based on the time taken for the cuticle to rupture upon exposure to bleach (commonly used in C. elegans research to dissolve mothers and liberate eggs), and relative permeability to fluorescent dyes19, 24, 26, 29, 31,32,33,34,35,36. Comparative bleach sensitivity data are shown in Fig. 2a and b. All the mutants tested displayed more rapid rupture at both larval and adult stages, indicating weakened cuticular integrity. Next, we tested uptake of two fluorescent dyes, acridine orange (AO) and 4′,6-diamidino-2-phenylindole (DAPI), in live L4 animals. The intensity of fluorescent dye accumulation was scored (Fig. 2c,d). All mutants showed increased dye permeability compared with the wild type (WT) control strain N2, with similar patterns of uptake observed for the two dyes. Where two alleles of the same gene were tested, the most permeable was selected for further analysis (bus-5(br19), bus-8(e2883) and bus-17(br2)).
Assessment of potential fitness trade-offs in cuticle mutants
It is possible that permeable mutants with compromised cuticle features would display phenotypic defects that would render them unattractive for toxicity testing. Therefore we investigated developmental speed and brood size in our selected alleles (Fig. 3). 75% of WT animals were laying eggs by day 2, whereas all the mutants tested exhibited some degree of delay, with bus-17 and bus-8 showing the greatest delay, coupled with the early death of a proportion of animals (Fig. 3a). In terms of brood size measurement (i.e. the total number of progeny per worm), all the mutants produced a significantly smaller brood (Fig. 3b), with bus-17 and bus-8 again showing the most dramatic decrease, significantly lower than the other three mutants. Based on these results, we concluded that bus-17 and bus-8 mutants were most compromised in terms of overall fitness and they were therefore excluded from subsequent analyses.
Chemical sensitivity in selected strains
To demonstrate the benefit of the sensitized strains for developmental and reproductive toxicity assays, we exposed L1 larvae to a small collection of chemicals with known toxicity effects on mammals (Table 1). Chemicals were dissolved in water, DMSO or a DMSO/isopropanol mix depending on solubility (see table legend). The maximum concentration of these solvents that did not show developmental toxicity was determined for wild type N2 and the selected mutant strains (Supplementary Figure S1), with the mutant strains not showing enhanced sensitivity. The three selected strains, agmo-1, bus-5 and bus-16 all showed enhanced sensitivity to a range of different chemicals (Table 1), confirming our hypothesis that the cuticle represents a significant impediment to chemical uptake. Some differences between the strains were observed, however, with bus-16 being least sensitive to most chemicals and bus-5 being the most sensitive.
Quantification of toxicological effects
Although this assay was successful in distinguishing acute toxicity from DART, it became apparent that different degrees of developmental delay could be observed in the different chemical exposures (and in the different strains), and that a non-subjective way of scoring these was required. The most visually striking event in our plate assay relates to consumption of the bacterial food by the worms. The time at which the bacterial lawn is completely cleared thus provides an objective, numerical readout of population size and health (i.e. developmental and reproductive rate). The day at which the strain grown in the absence of chemical completely depleted the food was set at zero, and delays induced by chemical exposure were noted, up to 10 days if necessary, thus providing a high degree of granularity to the assay. If chemical exposure led to either acute toxicity (death of P0 animals) or lack of viable progeny (no F1 animals), these were noted separately, as the bacterial lawn would never be depleted under these conditions. We validated this approach on a small range of compounds, including aldicarb (previously tested in Table 1) and two other compounds associated with DART, 2-phenoxyethanol and valproic acid (VPA). As a representative example, Fig. 4a shows photographs of the developmental delay in the presence of 4 nM aldicarb. At day 0 (i.e the day the control wells, containing strains not exposed to aldicarb, were cleared) some delay in food depletion was apparent in all strains including WT exposed to 4 nM aldicarb, with agmo-1 and bus-5 showing the fewest worms (and therefore the least food consumption). Analysis on subsequent days revealed that the delay is exacerbated in all three mutant strains, with bus-5 showing the greatest delay as bordering is still apparent on day 4 when all others had cleared the food. If this was scored as in Table 1, all three strains would have been scored the same, thus demonstrating the enhanced discriminatory power of the food depletion assay.
When this assay was performed using all three chemicals (Fig. 4b) enhanced sensitivity of mutant strains was confirmed. Thus, this assay can be used for distinct chemicals using different solvents (Fig. 4b) detecting both different degrees of DART and acute toxicity. For example, 8 nM aldicarb caused acute toxicity of bus-5 and agmo-1 worms, compared to DART in WT (N2) and bus-16 animals, whereas 18 mM VPA caused acute toxicity in bus-5 and bus-16 and DART in WT and agmo-1. bus-5 displayed acute toxicity at the highest concentration of all three chemicals tested and the highest level of DART following exposure to lower concentrations.
Alternative exposure protocol for volatile or insoluble compounds
Next, we considered how our exposure protocol could be adapted for use with volatile compounds that would be subject to evaporation from the surface of the wells. In addition, some compounds, such as toluene, showed no effect at the maximum concentration soluble in 1% DMSO (3 mM, data not shown). Vegetable oil has previously been used as an alternative solvent for exposure of worms to chemicals37. Chemical exposure is achieved by overlaying the entire surface of the well with oil containing the compound. The worms live at the interface between the oil and the solid media while being exposed to compound. We tested whether sunflower oil would affect development of the mutant strains relative to wild type and found that bus-16 displayed a developmental delay relative to WT when grown in the presence of oil (Fig. 5a) and so it was excluded from further analysis. Using this solvent allowed us to increase the concentration of toluene in chemical exposure studies to levels that revealed developmental effects (Fig. 5b). Both agmo-1 and bus-5 mutants showed enhanced sensitivity to toluene under these conditions.
Selection and validation of optimised testing strain
Taking into account all of the data, we concluded that bus-5 offers the optimal combination of chemical sensitivity and fitness. To validate this selection we compared the effect of a range of boric acid concentrations on bus-5 and wild type N2 worms (Fig. 6a). bus-5 animals showed increased sensitivity across a range of concentrations of boric acid, for example at 4.8 mM causing an enhanced delay to food depletion of 6 days compared to wild type. Finally, we assessed 2-methoxyethanol using the oil-based assay (Fig. 6b), as we had been unable to detect an effect on any strains in our standard plate assay. DART was only observed with bus-5, and not WT, revealing an effect that would otherwise have been missed.
Discussion
In this work we have established an enhanced, easily quantifiable C. elegans-based toxicity assay that has a number of advantages over currently available platforms, including cost, rapidity and the applicability associated with analysis of a whole organism throughout its developmental and reproductive life cycle. The assay provides robust data using very small amounts of chemicals in the 24-well plate format and can be easily established without the use of specialist equipment.
Importantly the assay can be exploited to reduce the number of vertebrate animals used in toxicity studies. The strength of the assay is its ability to identify high-risk compounds early in the discovery pipeline, when only small amounts may be available, and eliminate them before testing on animals. Similarly, the relatively high throughput offered by this C. elegans testing platform will facilitate medicinal chemistry approaches where promising lead compounds are associated with high toxicity risk. In this situation small quantities of a large number of related compounds can be tested to avoid key alerts.
In contrast to previously reported assays using C. elegans 13, 14, 16, 17, this platform integrates a variety of toxicological endpoints including acute toxicity, developmental delay and reproductive defects, thus offering a versatile testing platform with a considerable number of applications. Covering the complete developmental and reproductive cycle is predicted to reduce the number of false negative results in which chemicals with known toxicity in mammals do not show an effect when using assays with a single end-point14. We have tested our system on a range of chemicals of relevance to the agrochemical, pharmaceutical, cosmetics and petrochemical industries, thus demonstrating wide applicability. The compounds tested show toxicity by a wide variety of mechanisms as well as diversity in chemical structure, demonstrating the versatility of this assay.
We hypothesized that the cuticle presented a barrier to chemical uptake and therefore that worms with defects in cuticle structure would show enhanced sensitivity to chemicals due to increased uptake. Some cuticle integrity mutants have already been used to enhance the sensitivity of compound exposures38, 39, but there is no consensus on which strain is best. In this report, we have performed a comparative analysis of available strains with defects in the cuticle.
All the mutant strains showed some loss of fitness in terms of developmental timing and brood size. This was most apparent in the bus-17 and bus-8 mutants and these were not analysed further as the developmental defects would interfere with the assay for DART. All the remaining cuticle mutants tested showed enhanced sensitivity to a range of chemicals with varying properties, and using a range of solvents, suggesting that the worm cuticle does indeed represent a significant barrier to chemical uptake. The bus-16 mutant was discounted as it showed sensitivity to sunflower oil, a solvent useful for volatile chemicals37 and those with limited solubility in other solvents. Taking all the data into account, the cuticle barrier is best overcome in bus-5(br19) which offers optimal sensitivity without problematic loss of fitness. The use of bus-5 enables much lower concentrations of chemical to cause a robust toxicity outcome, in some cases facilitating detection of adverse outcome that would be missed using WT worms. C. elegans is also frequently used in screens to identify drugs causing defined phenotypic changes or to identify genes causing sensitivity or resistance to compounds by targeted reduction of gene expression using genome-wide RNAi40,41,42,43,44,45 Use of bus-5 will enhance the sensitivity of these screens, increasing the number of hits identified while using reduced amounts of chemical, which can be expensive or limiting in availability.
Overall, we propose that use of bus-5 could constitute a general replacement of the WT based platform for chemical toxicity screening in these circumstances. However, it will always be important to test chemical effects in more than one genetic background, even if a higher dose is required, to check that the response to a particular chemical is not specific to the mutant background used.
We do not envisage that C. elegans would ever completely replace vertebrates in toxicity testing. C. elegans could be usefully incorporated into a battery of assays (including other in vivo systems like zebrafish and in vitro cell-based assays as well as in silico modelling) to provide predictive power of a chemical’s toxicity towards humans. Such predictive toxicology would be useful in the elimination of high risk compounds early in product development. Use of C. elegans has added value not only in terms of animal replacement but also in the ability to exploit their genetic potential to provide detailed information of the pathways affected by chemicals. This will facilitate rational design of related compounds to minimise the potential for DART without compromising the useful properties of these compounds.
Methods
Strains and maintenance
C. elegans strains were cultivated as described46 and maintained at 20 °C. The strains Bristol N2 and LC144 [agmo-1(e3016)] III29 were obtained from the C. elegans Genetics Center (CGC, University of Minnesota, USA). The following strains were obtained from Jonathan Hodgkin (Dept of Biochemistry, University of Oxford, UK): CB7395 [bus-5(e2985)] X, DC19 [bus-5(br19)] X, CB6055 [bus-8(e2698)] X, CB6177 [bus-8(e2883)] X, CB5680 [bus-16(e2802)] X, CB5653 [him-5(e1490) V; bus-17(e2800) X] and CB7431 [bus-17(br2)] X. The him-5 mutation was crossed out of CB5653 to generate the strain AW1452 [bus-17(e2800)] X.
Genotyping primers
Strains were verified by PCR amplification of the relevant locus followed by DNA sequencing using the following primer pairs: XWO1 (5-aaaattaagaaccgcggtgactg) and XWO4 (5-aaaattctgcaaaaattggctcgc) for bus-17(e2800); XWO5 (5-gagaaaagctttggcggcg) and XWO8 (5-atgctcagccaatgcttcaag) for agmo-1(e3016); XWO9 (5-caggtcgatatggtgattcac) and XWO12 (5-ttccacatacatccaacttctag) for bus-5(br19).
Cuticle sensitivity and permeability assays
Cuticle sensitivity to hypochlorite was tested as described24, 29 with modifications. In brief, individual animals (L4 larvae or young gravid adults) were transferred into a 10 μl drop of freshly prepared 2%(v/v) alkaline hypochlorite solution (4 ml 5% sodium hypochlorite, 2.5 ml 4 N NaOH, 3.5 ml dH2O) on parafilm and the time taken until first visible rupture was noted.
Cuticle permeability to acridine orange (AO) and 4′,6-diamidino-2-phenylindole (DAPI) was assayed as described19, 26, 31, 34 with modifications. L4 larvae were washed from plates with M9 buffer prior to staining with AO or DAPI (5 μg/ml each in M9 buffer) for 15 minutes at room temperature with gentle agitation. Subsequently, worms were washed three times with M9 buffer, followed by fluorescence imaging. For microscopy, worms were mounted onto 3%(w/v) agarose pads, anaesthetised with 10 μl of 1 mM sodium azide and sealed with a coverslip before imaging on a Zeiss Axioplan 2 microscope. Samples were observed with a Zeiss Plan Neofluar 20x/0.50 Ph2 objective, images captured using a Zeiss AxioCam and the software AxioVision 4.8. AO or DAPI accumulation was imaged at 100msec exposure time, except for the strains CB7431 [bus-17(br2)] and AW1452 [bus-17(e2800)], where images were taken at 50msec exposure time.
Plate based toxicity assay
To synchronize worm populations, strains were washed from plates with M9 buffer, residual bacteria were removed by washing worms twice with M9 buffer prior to bleaching gravid adults using 1%(v/v) alkaline hypochlorite solution (2 ml 5% sodium hypochlorite, 1 ml 4 N NaOH, 7 ml dH2O) to obtain eggs. Wild type N2 worms dissolved after 10–12 minutes at room temperature, while all mutant strains required 3–5 minutes to dissolve. Hypochlorite was removed by washing the eggs three times with M9 buffer. Eggs were left to hatch overnight at 15 °C to give rise to a population of synchronized L1 larvae. Each well of a 24-well plate containing 500 μl NGM agar was seeded with 20 μl of Escherichia coli (OP50) from an overnight culture. The bacterial lawn was allowed to grow at room temperature for two days. For exposure to chemicals dissolved in water, 1%(v/v) DMSO or a mixture containing 1%(v/v) DMSO and 5%(v/v) isopropanol a 30 μl drop of each chemical at the appropriate concentration (or solvent control), sufficient to cover the entire surface of the well, was dried on the agar at room temperature for 30 min in a laminar flow hood. Once the bacterial plates were prepared in this way, five synchronized L1 larvae were picked onto each well. Plates were incubated at 20 °C and an image of each individual well was captured daily using a Leica MZFLIII microscope and Hamamatsu digital camera (Orca-05G) until the bacterial lawn was completely consumed by the worms.
To calculate chemical exposure concentration, the volume of agar was taken into account. For instance, dropping 30 μl of 20 mM boric acid onto 500 μl NGM agar resulted in a final concentration of 1.2 mM boric acid during exposure of L1 larvae. Each chemical concentration was tested in at least three replicate wells.
For exposure to volatile chemicals, e.g. toluene and 2-methoxyethanol, chemicals were mixed with sunflower oil before layering each seeded well with 0.5 ml of chemical-oil mix above the bacterial lawn, after adding the worms. Plates were sealed with parafilm throughout the experiment.
Brood size determination
L4 larvae (n = 20 animals per strain) were maintained individually under standard conditions. At the onset of egg-laying worms were transferred to a fresh plate daily until egg laying ceased (around 3 days). Progeny from each plate were counted and added together.
Assessment of developmental fitness
L1 larvae (n = 28 animals per strain) were maintained individually under standard conditions and the number of animals in each developmental stage was noted every 24 hours for three days until egg-laying began.
Statistical analyses
All statistical analyses were performed using GraphPad Prism. Significance for hypochlorite sensitivity and brood size of individual strains was tested by multiple comparisons using one-way ANOVA. Statistical significance for delay in food depletion during chemical exposure was analysed by comparison of mutant strains to wild type N2 using two-way ANOVA tests.
Data availability statement
All data generated or analysed during this study are included in this published article (and its Supplementary Information files).
References
Hartung, T. & Rovida, C. Chemical regulators have overreached. Nature 460, 1080–1081 (2009).
Burden, N., Sewell, F. & Chapman, K. Testing Chemical Safety: What Is Needed to Ensure the Widespread Application of Non-animal Approaches? PLoS Biol. 13 (2015).
Lai, C. H., Chou, C. Y., Ch’ang, L. Y., Liu, C. S. & Lin, W. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res. 10, 703–13 (2000).
Lehner, B., Crombie, C., Tischler, J., Fortunato, A. & Fraser, A. G. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 38, 896–903 (2006).
Markaki, M. & Tavernarakis, N. Modeling human diseases in Caenorhabditis elegans. Biotechnol. J 5, 1261–1276 (2010).
O’Reilly, L. P., Luke, C. J., Perlmutter, D. H., Silverman, G. A. & Pak, S. C. C. elegans in high-throughput drug discovery. Advanced Drug Delivery Reviews 69–70, 247–253 (2014).
Dengg, M. & van Meel, J. C. A. Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J. Pharmacol. Toxicol. Methods 50, 209–214 (2004).
Kaletta, T. & Hengartner, M. O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5, 387–98 (2006).
Leung, M. C. K. et al. Caenorhabditis elegans: An emerging model in biomedical and environmental toxicology. Toxicological Sciences 106, 5–28 (2008).
Martinez-Finley, E. J., Avila, D. S., Chakraborty, S. & Aschner, M. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases. Metallomics 3, 271–9 (2011).
Avila, D., Helmcke, K. & Aschner, M. The Caenorhabiditis elegans model as a reliable tool in neurotoxicology. Hum. Exp. Toxicol. 31, 236–43 (2012).
Allard, P., Kleinstreuer, N. C., Knudsen, T. B. & Colaiácovo, M. P. Disruption of Germline Function. Env. Heal. Perspect 121, 717–724 (2013).
Boyd, W. A., Smith, M. V., Kissling, G. E. & Freedman, J. H. Medium- and high-throughput screening of neurotoxicants using C. elegans. Neurotoxicol Teratol. 32, 68–73 (2010).
Harlow, P. H. et al. The nematode Caenorhabditis elegans as a tool to predict chemical activity on mammalian development and identify mechanisms influencing toxicological outcome. Sci. Rep. 6, 22965 (2016).
Boyd, W. A. et al. Developmental Effects of the ToxCastTM Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits. Env. Heal. Perspect. 124, 586–593 (2016).
Boyd, W. A., Smith, M. V. & Freedman, J. H. Caenorhabditis elegans as a model in developmental toxicology. Methods Mol Biol. 889, 15–24 (2012).
Boyd, W. A., Mcbride, S. J., Rice, J. R., Snyder, D. W. & Freedman, J. H. A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay. Toxicol Appl Pharmacol. 245, 153–159 (2010).
Johnstone, I. L. Cuticle collagen genes. Trends Genet. 16, 21–27 (2000).
Fritz, J. A. & Behm, C. A. CUTI-1: A novel tetraspan protein involved in C. elegans CUTicle formation and epithelial integrity. PLoS One 4 (2009).
Taffoni, C. & Pujol, N. Mechanisms of innate immunity in C. elegans epidermis. Tissue Barriers. 8370, e1078432 (2015).
Carre-Pierrat, M. et al. Blocking of striated muscle degeneration by serotonin in C. elegans. J. Muscle Res. Cell Motil. 27, 253–258 (2006).
Giacomotto, J. & Segalat, L. High-throughput screening and small animal models, where are we? Br. J. Pharmacol. 160, 204–216 (2010).
Burns, A. R. et al. A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans. Nat Chem Biol. 6, 549–557 (2010).
Gravato-Nobre, M. J. et al. Multiple genes affect sensitivity of Caenorhabditis elegans to the bacterial pathogen Microbacterium nematophilum. Genetics 171, 1033–1045 (2005).
Gravato-nobre, M. J., Stroud, D., Rourke, D. O., Darby, C. & Hodgkin, J. Glycosylation genes expressed in seam cells determine complex surface properties and bacterial adhesion to the cuticle of Caenorhabditis elegans. Genetics 187, 141–155 (2011).
Partridge, F. A., Tearle, A. W., Gravato-Nobre, M. J., Schafer, W. R. & Hodgkin, J. The C. elegans glycosyltransferase BUS-8 has two distinct and essential roles in epidermal morphogenesis. Dev. Biol. 317, 549–559 (2008).
Feng, L., Shou, Q. & Butcher, R. A. Identification of a dTDP-rhamnose biosynthetic pathway that oscillates with the molting cycle in Caenorhabditis elegans. Biochem J. 473, 1507–1521 (2016).
Yook, K. & Hodgkin, J. Mos1 Mutagenesis Reveals a Diversity of Mechanisms Affecting Response of Caenorhabditis elegans to the Bacterial Pathogen Microbacterium nematophilum. Genetics 175, 681–697 (2007).
Loer, C. M. et al. Cuticle integrity and biogenic amine synthesis in Caenorhabditis elegans require the cofactor tetrahydrobiopterin (BH4). Genetics 200, 237–253 (2015).
Burns, A. R. et al. High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans. Nat Protoc. 1, 1906–1914 (2006).
Moribe, H. et al. Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans. J. Cell Sci. 117, 5209–5220 (2004).
Hirani, N., Westenberg, M., Seed, P. T. & Dolphin, C. T. C. elegans flavin-containing monooxygenase-4 is essential for osmoregulation in hypotonic stress. Biol. Open 5, 537–49 (2016).
Ward, J. D. et al. Defects in the C. elegans acyl-CoA synthase, acs-3, and nuclear hormone receptor, nhr-25, cause sensitivity to distinct, but overlapping stresses. PLoS One 9, e92552 (2014).
Li, Y. & Paik, Y.-K. A potential role for fatty acid biosynthesis genes during molting and cuticle formation in Caenorhabditis elegans. BMB Rep. 44, 285–290 (2011).
Meli, V. S., Osuna, B., Ruvkun, G. & Frand, A. R. MLT-10 defines a family of DUF644 and proline-rich repeat proteins involved in the molting cycle of Caenorhabditis elegans. Mol. Biol. Cell 21, 1648–1661 (2010).
Thein, M. C. et al. Combined extracellular matrix cross-linking activity of the peroxidase MLT-7 and the dual oxidase BLI-3 is critical for post-embryonic viability in Caenorhabditis elegans. J. Biol. Chem. 284, 17549–17563 (2009).
Kokel, D. & Xue, D. A class of benzenoid chemicals suppresses apoptosis in C. elegans. ChemBioChem 7, 2010–2015 (2006).
Law, W. et al. Heterologous Expression in Remodeled C. elegans: A Platform for Monoaminergic Agonist Identification and Anthelmintic Screening. PLoS Pathog. 11, e1004794 (2015).
Kudelska, M. M., Holden-Dye, L., O’Connor, V. & Doyle, D. A. Concentration-dependent effects of acute and chronic neonicotinoid exposure on the behaviour and development of the nematode Caenorhabditis elegans. Pest Manag Sci. 73, 1345–1351 (2017).
Reichert, K. & Menzel, R. Expression profiling of five different xenobiotics using a Caenorhabditis elegans whole genome microarray. Chemosphere 61, 229–237 (2005).
Gosai, S. J. et al. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z. PLoS One 5 (2010).
O’Reilly, L. P. et al. A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency. Hum. Mol. Genet. 23, 5123–5132 (2014).
Hughes, S., Brabin, C., Appleford, P. J. & Woollard, A. CEH-20/Pbx and UNC-62/Meis function upstream of rnt-1/Runx to regulate asymmetric divisions of the C. elegans stem-like seam cells. Biol. Open 2, 718–27 (2013).
Artal-Sanz, M., de Jong, L. & Tavernarakis, N. Caenorhabditis elegans: A versatile platform for drug discovery. Biotechnology Journal 1, 1405–1418 (2006).
Kim, W., Hendricks, G. L., Lee, K. & Mylonakis, E. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs. Expert Opin. Drug Discov. 12, 625–633 (2017).
Brenner, S. The genetics of C.elegans. Methods 77, 71–94 (1974).
Acknowledgements
This work was funded by NC3Rs Ref: NC/M000834/1. We are grateful to Jonathan Hodgkin for the provision of strains and Liisa Parts for useful discussions regarding plate-based toxicity assays. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).
Author information
Authors and Affiliations
Contributions
H.X., C.P. and A.W. designed the study. H.X. performed the experiments, H.X., C.P. and A.W. analysed the data. H.X., C.P. and A.W. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xiong, H., Pears, C. & Woollard, A. An enhanced C. elegans based platform for toxicity assessment. Sci Rep 7, 9839 (2017). https://doi.org/10.1038/s41598-017-10454-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-10454-3
- Springer Nature Limited